FDA
-
-
-
-
-
-
-
23andMe Holding (ME) Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs
-
-
-
-
-
-
-
23andMe Launches Total Health™, its Comprehensive, Prevention-Based Health Membership
-
-
-
-
-
-
-
23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results
-
-
-
-
-
-
-
23andMe Holding (ME) Granted New FDA Clearance to Provide Interpretive Drug Information for a Commonly Prescribed Cholesterol Medication
-
-
-
-
-
-
-
23andMe Reports FY2023 First Quarter Financial Results
-
-
-
-
-
-
-
23andMe to Present at Cowen 42nd Annual Health Care Conference
-
-
-
-
-
-
-
23andMe to Report FY2022 Third Quarter Financial Results
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

